Smejkal P - Search Results

1

A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome.

Skalníková M, Staňo Kozubík K, Trizuljak J, Vrzalová Z, Radová L, Réblová K, Holbová R, Kurucová T, Svozilová H, Štika J, Blaháková I, Dvořáčková B, Prudková M, Stehlíková O, Šmída M, Křen L, Smejkal P, Pospíšilová Š, Doubek M. Skalníková M, et al. Among authors: smejkal p. Int J Mol Sci. 2022 Jan 14;23(2):885. doi: 10.3390/ijms23020885. Int J Mol Sci. 2022. PMID: 35055070 Free PMC article.

2

A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome.

Trizuljak J, Kozubík KS, Radová L, Pešová M, Pál K, Réblová K, Stehlíková O, Smejkal P, Zavřelová J, Pacejka M, Mayer J, Pospíšilová Š, Doubek M. Trizuljak J, et al. Among authors: smejkal p. Platelets. 2018 Dec;29(8):827-833. doi: 10.1080/09537104.2018.1529300. Epub 2018 Oct 17. Platelets. 2018. PMID: 30332551

3

[Hereditary thrombocytopenia. Differential diagnosis of a case].

Doubek M, Smejkal P, Dostálová V, Trnavská I, Buliková A, Brychtová Y, Mayer J. Doubek M, et al. Among authors: smejkal p. Cas Lek Cesk. 2003;142(11):683-6. Cas Lek Cesk. 2003. PMID: 14689830 Czech.

4

A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.

Vangenechten I, Mayger K, Smejkal P, Zapletal O, Michiels JJ, Moore GW, Gadisseur A. Vangenechten I, et al. Among authors: smejkal p. J Thromb Haemost. 2018 Jul;16(7):1268-1277. doi: 10.1111/jth.14145. Epub 2018 Jun 6. J Thromb Haemost. 2018. PMID: 29742318 Free article.

5

Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study.

Vangenechten I, Smejkal P, Zapletal O, Michiels JJ, Berneman Z, Zavrelova J, Blatný J, Penka M, Gadisseur A. Vangenechten I, et al. Among authors: smejkal p. Thromb Haemost. 2019 Apr;119(4):594-605. doi: 10.1055/s-0039-1678528. Epub 2019 Feb 5. Thromb Haemost. 2019. PMID: 30722078

6

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test.

Michiels JJ, Smejkal P, Penka M, Batorova A, Pricangova T, Budde U, Vangenechten I, Gadisseur A. Michiels JJ, et al. Among authors: smejkal p. Clin Appl Thromb Hemost. 2017 Sep;23(6):518-531. doi: 10.1177/1076029616647157. Epub 2016 Jul 21. Clin Appl Thromb Hemost. 2017. PMID: 27443694 Free article. Review.

7

[Combined surgical treatment of portal hypertension].

Kala Z, Silhart Z, Hanke I, Kysela P, Nĕmec M, Novotný I, Bulíková A, Smejkal P. Kala Z, et al. Among authors: smejkal p. Rozhl Chir. 1998 Oct;77(10):445-9. Rozhl Chir. 1998. PMID: 9863349 Czech.

8

The use of recombinant-activated factor VII in von Willebrand disease: a case series.

von Depka M, Hassan M, Blatnŷ J, Smejkal P, Vdovin V. von Depka M, et al. Among authors: smejkal p. Blood Coagul Fibrinolysis. 2006 Jun;17(4):311-6. doi: 10.1097/01.mbc.0000224852.42625.0d. Blood Coagul Fibrinolysis. 2006. PMID: 16651875

9

[Von Willebrand disease].

Smejkal P, Matýsková M, Penka M. Smejkal P, et al. Vnitr Lek. 2008 Mar;54(3):257-64. Vnitr Lek. 2008. PMID: 18522294 Review. Czech.

10

Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic.

Salaj P, Penka M, Smejkal P, Geierova V, Ovesná P, Brabec P, Cetkovsky P, Kubes R, Mesterton J, Lindgren P. Salaj P, et al. Among authors: smejkal p. Thromb Res. 2012 May;129(5):e233-7. doi: 10.1016/j.thromres.2012.02.005. Epub 2012 Mar 2. Thromb Res. 2012. PMID: 22386136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page